If no other option help...
Key Market Indicator:
F&G: 63
25.547,95 NASDAQ · 49.390,00 DOW · 6.947,26 S&P · 4.596,86 Gold · 63,45 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
© Newsfile
16.01.2026
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress
News Preview
Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is providing a summary of key developments achieved during 2025 across its Research and Development programs, technical capabilities, clinical initiatives, and glo...
Themefolio
Profiler
Peergroup
© Newsfile
26.09.2025
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Devices Announces NHS Drug Tariff Approval for EziAutoJector(R) Product Line in the UK
News Preview
Toronto, Ontario--(Newsfile Corp. - September 26, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is pleased to announce that its exclusive UK distribution partner, EziAutoJector® Ltd, has received confirmation from the NHS Business Services Authority, o...
Themefolio
Profiler
Peergroup
© Newsfile
21.08.2025
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Devices Announces New Needle-Free Injection System Featuring Internal Cartridge Technology
News Preview
Toronto, Ontario--(Newsfile Corp. - August 21, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, is pleased to announce research and development of a next-generation needle-free injection system, in drug delivery technology. This innovation, protected under int...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar

USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Newsfile
07.07.2025
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
InsuJet Distribution Expands Across France
News Preview
NuGen Medical Devices Launches French InsuJet(TM) e-Commerce Platform, Delivering Needle-Free Insulin with On-Demand Clinical SupportToronto, Ontario--(Newsfile Corp. - July 7, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle-free subcutaneous drug-delivery technology, today unveiled www.insujet.fr R...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Newsfile
30.04.2025
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Announces Release of 2024 Annual Financial Results
News Preview
Toronto, Ontario--(Newsfile Corp. - April 30, 2025) -  NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices for the subcutaneous administration of therapeutics, announces the release of 2024 Annual Financial Results. Annual Financial Statements Reflect Commercial Ramp UpThe orders announ...
Themefolio
Profiler
Peergroup
© Newsfile
24.04.2025
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
InsuJet Distribution Expands Across Canada
News Preview
Toronto, Ontario--(Newsfile Corp. - April 24, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is please to report that distribution of The InsuJet™ will be expanded with increased availability across Canada connecting alongside hea...
Themefolio
Profiler
Peergroup
© Newsfile
14.01.2025
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Announces the Appointment of Liang Lin as Chief Executive Officer
News Preview
Toronto, Ontario--(Newsfile Corp. - January 14, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce the appointment of Mr. Liang Lin as the new Chief Executive Officer of NuGen. Liang is the founder and CEO of Sol-Mill...
Themefolio
Profiler
Peergroup
© Newsfile
22.11.2024
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Announces Canada-Wide Launch of InsuJet
News Preview
3,250 InsuJet Starter Packs Being Delivered to Pharmacies Across CanadaToronto, Ontario--(Newsfile Corp. - November 22, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce the national launch of InsuJet™ in Canad...
Themefolio
Profiler
Peergroup
© Newsfile
14.11.2024
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Announces Results of Special Meeting and Appointment of New Directors
News Preview
Toronto, Ontario--(Newsfile Corp. - November 14, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that its shareholders have approved Sol-Millennium Medical HK Limited ("Sol-M") and Nature Health Development (Hong K...
Themefolio
Profiler
Peergroup
© Newsfile
25.10.2024
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Announces Strategic Partnership with EziAutoJector Limited
News Preview
5,000 InsuJet devices to be delivered to the UKToronto, Ontario--(Newsfile Corp. - October 25, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce a strategic partnership with EziAutoJector® Limited ("EziAutoJecto...
Themefolio
Profiler
Peergroup
© Newsfile
20.09.2024
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Announces Closing of Private Placement of $10 million Secured Convertible Debentures
News Preview
Toronto, Ontario--(Newsfile Corp. - September 20, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that, further to its press release dated August 15, 2024, Sol-Millennium Medical HK Limited ("Sol-M") and Nature Hea...
Themefolio
Profiler
Peergroup
© Newsfile
29.08.2024
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Announces Release of Financial Results for Q2 2024 & Update on Proposed Private Placement
News Preview
Toronto, Ontario--(Newsfile Corp. - August 29, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices for the subcutaneous administration of therapeutics, announces the release of Q2 2024 Financial Results and is pleased to provide updates on commercial progress and its proposed private...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
21.08.2024
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Announces Voting Results of Annual and Special Meeting
News Preview
Toronto, Ontario--(Newsfile Corp. - August 21, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce voting results from the annual and special meeting of the Company's shareholders (the "Meeting") held on August 20, 202...
Themefolio
Profiler
Peergroup
© Newsfile
15.08.2024
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Announces Revised Terms of Proposed Private Placement of up to $10 Million Secured Convertible Debentures
News Preview
Toronto, Ontario--(Newsfile Corp. - August 15, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, announces that price protection has expired for its proposed non-brokered private placement (the "Offering") of up to $10,000,000 principal am...
Themefolio
Profiler
Peergroup
© Newsfile
19.07.2024
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Receives Order for Repeat Demand in Mexico
News Preview
Toronto, Ontario--(Newsfile Corp. - July 19, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that Science Link, the exclusive distributor of the InsujetTM in Mexico has placed an additional order for 4,500 Insujet...
Themefolio
Profiler
Peergroup
© Newsfile
10.07.2024
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Announces Proposed Private Placement of up to $10 million Secured Convertible Debentures
News Preview
Toronto, Ontario--(Newsfile Corp. - July 10, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce its intention to complete a non-brokered private placement (the "Offering") of up to $10,000,000 principal amount secured...
Themefolio
Profiler
Peergroup
© Newsfile
09.07.2024
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Develops Pharmacist Training Packages for the Canadian Retail Pharmacy Market
News Preview
Toronto, Ontario--(Newsfile Corp. - July 9, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that it has formed a three-way partnership with Wholehealth Pharmacy Partners ("Wholehealth") and Sol-Millennium Medical G...
Themefolio
Profiler
Peergroup
© Newsfile
01.07.2024
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Announces Completion of InsuJet(TM) Training with Sol-Millennium(TM) Brazil
News Preview
Toronto, Ontario--(Newsfile Corp. - July 1, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that as of June 26, 2024, the commercial teams of Sol-MillenniumTM Medical Inc. ("Sol-MTM") in Brazil have successfully co...
Themefolio
Profiler
Peergroup
© Newsfile
28.06.2024
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Announces Repeat Order for Growing InsuJet(TM) Demand in Yemen
News Preview
Toronto, Ontario--(Newsfile Corp. - June 28, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that Rosheta for Medicines and Medical Supplies ("Rosheta"), NuGen's exclusive distributor in Yemen, has placed a second...
Themefolio
Profiler
Peergroup
© Newsfile
21.06.2024
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Announces Initial Purchase Order from Sol-Millennium(TM) for Pharmacy Launches in the Canadian and European Markets
News Preview
Toronto, Ontario--(Newsfile Corp. - June 21, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices for the subcutaneous administration of therapeutics, is pleased to announce that Sol-MillenniumTM Medical Inc. ("Sol-M") has placed its initial purchase order of 3,832 InsuJetTM injectors...
Themefolio
Profiler
Peergroup
© Newsfile
30.05.2024
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Announces Release of Financial Results for Q1 2024 & Updates on Strong Commercial Momentum in Q2
News Preview
Toronto, Ontario--(Newsfile Corp. - May 30, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, announces the release Q1 2024 Financial Results and is pleased to provide an update on the strong commercial progress made year to date. Q1 Finan...
Themefolio
Profiler
Peergroup
© Newsfile
15.04.2024
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Announces Debt Settlement and Amendments to Care4Pharma Share Purchase Agreement
News Preview
Toronto, Ontario--(Newsfile Corp. - April 15, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") announces that it has agreed to settle an aggregate of €275,000 of indebtedness owed to Care4Pharma B.V. ("Care4Pharma"), an arm's length creditor (the "Creditor"), with respect to monies owed pursuant to the share purchase...
Themefolio
Profiler
Peergroup
© Newsfile
30.01.2024
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Announces Completion of Product Training with Sol Millennium as European Markets Expand
News Preview
Toronto, Ontario--(Newsfile Corp. - January 30, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that as of January 30th, 2024, Sol-Millennium Medical Inc.'s ("Sol-M") global sales & marketing team has now compl...
Themefolio
Profiler
Peergroup
© Newsfile
19.01.2024
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Receives Two Additional Sales Orders for InsuJet(TM) and Expands Distribution into Argentina, Chile, Costa Rica and Peru
News Preview
Toronto, Ontario--(Newsfile Corp. - January 19, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to report that its distribution partner in Mexico, Science-Link Trading SAPI de CV ("Science-Link") has expanded their distributio...
Themefolio
Profiler
Peergroup
© Newsfile
19.12.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Signs 5-year Distribution Agreement for InsuJet(TM) with Verrue Consulting Group in Belgium
News Preview
Toronto, Ontario--(Newsfile Corp. - December 19, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that as of December 17, 2023, Verrue Consulting Group BV ("Verrue"), a limited liability company incorporated under t...
Themefolio
Profiler
Peergroup
© Newsfile
14.12.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Signs 5-Year Distribution Agreement for InsuJet(TM) with Advance Medical Life Co.
News Preview
Toronto, Ontario--(Newsfile Corp. - December 14, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that, as of December 12, 2023, Advance Medical Life Co. Ltd. ("Advance Medical"), a limited liability company domicil...
Themefolio
Profiler
Peergroup
© Newsfile
13.11.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
InsuJet(TM) Registered as a Medical Device in Mexico
News Preview
Second Bulk Sale for InsuJet(TM) Now Paid in FullToronto, Ontario--(Newsfile Corp. - November 13, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce the Mexican government has completed the registration of NuGen's needle-free InsuJet™ injection device for sale throughout the country as a medical...
Themefolio
Profiler
Peergroup
© Newsfile
07.11.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
Diabetic Lifestyle Subscription Business Launched on Shopify as NuGen's B2C Business Vertical
News Preview
www.insujet.com - a diabetic e-commerce storeToronto, Ontario--(Newsfile Corp. - November 7, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce the official launch on Shopify of its diabetic's lifestyle subscription b...
Themefolio
Profiler
Peergroup
© Newsfile
02.11.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
MedTech Industry Leader Ian Heynen Commences CEO Role at NuGen
News Preview
Toronto, Ontario--(Newsfile Corp. - November 2, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to report that Mr. Ian Heynen has commenced his role as the Company's new Chief Executive Officer focusing his attention on fully...
Themefolio
Profiler
Peergroup
© Newsfile
12.10.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Appoints Industry Leader Ian Heynen as CEO
News Preview
Toronto, Ontario--(Newsfile Corp. - October 12, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle free devices to administer therapeutics subcutaneously, is pleased to announce it has appointed Mr. Ian Heynen as the Company's new Chief Executive Officer, effective November 1, 2023.Mr. Heynen is...
Themefolio
Profiler
Peergroup
© Newsfile
10.10.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
Semaglutide - Ozempic(R) is Chemically Stable When Administered Using NuGen's Needle Free InsuJet(TM) Device
News Preview
Toronto, Ontario--(Newsfile Corp. - October 10, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle free devices to administer therapeutics subcutaneously, today presented new data from a preliminary trial that semaglutide (Ozempic®) is chemically stable after it is administered through NuGe...
Themefolio
Profiler
Peergroup
© Newsfile
20.09.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Completes Delivery and First Sale of 500 InsuJet(TM) Devices and Consumables in Romania
News Preview
Toronto, Ontario--(Newsfile Corp. - September 20, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to report it has completed the delivery and sale of the first 500 units of the Company's needle-free InsuJet™ injector device and consumables to SC Trustmed SRL ("Trustmed") in Romania as previously announced...
Themefolio
Profiler
Peergroup
© Newsfile
11.09.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Receives $1.3M Through Early Option and Warrant Exercise
News Preview
Toronto, Ontario--(Newsfile Corp. - September 11, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to report it has received $1,302,000 through the exercise of 25,290,000 warrants having an exercise price of $0.05 expiring February 14, 2025, and 750,000 options at $0.05 expiring December 13, 2027."The early exer...
Themefolio
Profiler
Peergroup
© Newsfile
05.09.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Announces Participation at the 2023 Kinvestor Days Virtual Conference Tech Day
News Preview
Toronto, Ontario--(Newsfile Corp. - September 5, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen"), is pleased to announce that Richard Buzbuzian, NuGen's President, CEO and Director, and Karen Dunlap, Chief Customer Officer and Director, are scheduled to present at the 2023 Kinvestor Days Virtual Conference on September 20...
Themefolio
Profiler
Peergroup
© Newsfile
04.08.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Provides Corporate Update
News Preview
Toronto, Ontario--(Newsfile Corp. - August 4, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to provide shareholders the following corporate update.Corporate mission:NuGen's mission is to reduce the daily burden of diabetes care by providing a needle-free insulin injection device and supplies tailored to each...
Themefolio
Profiler
Peergroup
© Newsfile
26.07.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
RETRANSMISSION: NuGen Signs $204M Distribution Agreement With Global Leader in the Diabetic Industry
News Preview
Toronto, Ontario--(Newsfile Corp. - July 26, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce it has entered into a distribution agreement for its needle-free InsuJet™ medical device and consumables with Sol-Millennium Medical Inc. ("Sol-M") of Chicago, Illinois USA, for a term of five years wh...
Themefolio
Profiler
Peergroup
© Newsfile
26.07.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Signs $204M Distribution Agreement With Global Leader in the Diabetic Industry
News Preview
Toronto, Ontario--(Newsfile Corp. - July 25, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce it has entered into a distribution agreement for its needle-free InsuJet™ medical device and consumables with Sol-Millennium Medical Inc. ("Sol-M") of Chicago, Illinois USA, for a term of five years wh...
Themefolio
Profiler
Peergroup
© Newsfile
30.06.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Ships First InsuJet(TM) Devices and Consumables to the UK and Attends Diabetes Professional Care Conference
News Preview
Toronto, Ontario--(Newsfile Corp. - June 30, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce that it has delivered its first shipment of InsuJet™ devices and consumables to Reliance Medical Ltd., the Company's UK distributor and 3PL partner in the UK.NuGen further announces their attendance at...
Themefolio
Profiler
Peergroup
© Newsfile
23.06.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Devices Receives First Bulk-Order Payment and Will Ship 500 InsuJets(TM) to Mexico
News Preview
National Health System (NHS) of the UK lists InsuJet(TM) in its online tariff listToronto, Ontario--(Newsfile Corp. - June 23, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce that it has received payment for the first shipment of InsuJet™, our needle-free insulin delivery system, to its Mexica...
Themefolio
Profiler
Peergroup
© Newsfile
16.06.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Sells 800 InsuJet(TM) Devices and Consumables in Yemen
News Preview
Toronto, Ontario--(Newsfile Corp. - June 16, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to report it has sold 800 units of the Company's needle-free InsuJet™ injector device and consumables to Rosheta for Medicines and Medical Supplies in Yemen. The Company anticipates further sales to Rosheta for Me...
Themefolio
Profiler
Peergroup
© Newsfile
14.06.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
Porter Media Engaged by NuGen Medical for Online Marketing of InsuJet(TM)
News Preview
Beginning with the United KingdomToronto, Ontario--(Newsfile Corp. - June 14, 2023) -  NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce it has engaged Porter Media, a growth marketing team that specializes in scaling online businesses, to develop product awareness and grow sales of the Company's needle-...
Themefolio
Profiler
Peergroup
© Newsfile
12.06.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Sells 500 InsuJet(TM) Devices and Consumables in Romania
News Preview
Toronto, Ontario--(Newsfile Corp. - June 12, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to report it has sold 500 units of the Company's needle-free InsuJet™ injector device and consumables to Trustmed SRL in Romania. The Company anticipates further sales from Trustmed SRL and will report such sales...
Themefolio
Profiler
Peergroup
© Newsfile
09.06.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
InsuJet(TM) Now Registered on NHS Drug Tariff - Covered by Prescription
News Preview
Reliance Medical Group - UK Distributor, 3PL PartnerToronto, Ontario--(Newsfile Corp. - June 9, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce InsuJet™ is now registered for supply through the NHS Drug Tariff. Reliance Medical Group ("Reliance Medical") has been appointed as our 3PL partner a...
Themefolio
Profiler
Peergroup
© Newsfile
06.06.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
DSRUPT Engaged by NuGen Medical for Online Marketing
News Preview
Toronto, Ontario--(Newsfile Corp. - June 6, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce it has engaged Dsrupt Media Inc. ("DSRUPT") to develop product awareness and grow sales of NuGen's needle-free InsuJet™ medical device, targeting diabetics around the world. InsuJet™ is approved f...
Themefolio
Profiler
Peergroup
© Newsfile
02.06.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Announces First Bulk Purchase Order for InsuJet(TM)
News Preview
Toronto, Ontario--(Newsfile Corp. - June 2, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce it has received its first bulk purchase order from Science-Link Trading SAPI de CV ("Science-Link"), a company in Mexico, for the Mexican market for 500 units of the Company's needle-free InsuJet™ injec...
Themefolio
Profiler
Peergroup
© Newsfile
30.05.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Devices to Hold Investor Lunch Presentation in Toronto, Ontario on June 15th, 2023
News Preview
Toronto, Ontario--(Newsfile Corp. - May 30, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce that it is hosting an investor lunch presentation on June 15th at Modus Restaurant, located at 145 King Street West, Toronto, Ontario M5H 1J8 at 12:00 p.m. EDT, limited to 70 attendees. "Maintaining the philo...
Themefolio
Profiler
Peergroup
© Newsfile
29.05.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Devices Announces Services Agreement
News Preview
Toronto, Ontario--(Newsfile Corp. - May 29, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") announces that, further to its press release dated February 28, 2023, it has entered into an amended and restated agreement (the "Agreement") dated May 29, 2023 with bullVestor Medien GmbH ("bullVestor"), an arm's-length party to t...
Themefolio
Profiler
Peergroup
© Newsfile
18.05.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Devices Announces Closing of $450,000 Non-Brokered Private Placement of Units
News Preview
Toronto, Ontario--(Newsfile Corp. - May 18, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") announces that it has closed a non-brokered private placement of units (the "Offering") through the issuance of 2,500,000 units (each a "Unit") at a price of $0.18 per Unit for aggregate gross proceeds of $450,000."As a result of s...
Themefolio
Profiler
Peergroup
© Newsfile
25.04.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Devices Announces Closing of $4,000,000 Non-Brokered Private Placement of Units
News Preview
Toronto, Ontario--(Newsfile Corp. - April 25, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company") announces that it has closed its non-brokered private placement of units (the "Offering") through the issuance of 22,222,222 units (each a "Unit") at a price of $0.18 per Unit for aggregate gross proceeds of $4,000,000. "Strong i...
Themefolio
Profiler
Peergroup
© Newsfile
21.04.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Devices Announces Upsize to Non-Brokered Private Placement of Units
News Preview
Toronto, Ontario--(Newsfile Corp. - April 21, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company") is pleased to announce that, further to its press release of March 31, 2023, its previously announced non-brokered private placement of units (each, a "Unit") at a price of $0.18 per Unit has been upsized to 22,222,222 Units for aggregate g...
Themefolio
Profiler
Peergroup
© Newsfile
10.04.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Commences Feasibility Study, Validation and Testing for Semaglutide - "Ozempic(R)"
News Preview
Toronto, Ontario--(Newsfile Corp. - April 10, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") announces it has engaged Basic Pharma Technologies, a pharmaceutical company located in the Netherlands, to perform an assessment and feasibility study, which will include validation testing of semaglutide if administered using N...
Themefolio
Profiler
Peergroup
© Newsfile
04.04.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical to Hold Its First Ever Investor Night in Vaughan, Ontario
News Preview
Toronto, Ontario--(Newsfile Corp. - April 4, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce it is hosting its first Investors Presentation night in Vaughan, Ontario on April 20, 2023 at 7:00 p.m. EST."We have always maintained the philosophy of treating our Investor's as customers and cordially inv...
Themefolio
Profiler
Peergroup
© Newsfile
03.04.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Appoints Louise Cresswell as Commercial Lead - United Kingdom
News Preview
Toronto, Ontario--(Newsfile Corp. - April 3, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce the appointment of Louise Cresswell as the Commercial Lead for the United Kingdom. Ms. Cresswell has an extensive background working in the UK health sector both as a registered nurse and in commercial, sale...
Themefolio
Profiler
Peergroup
© Newsfile
31.03.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical to Raise Up to $3.6 Million in Non-Brokered Private Placement
News Preview
Toronto, Ontario--(Newsfile Corp. - March 31, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") announces it intends to complete a non-brokered private placement of up to $3,600,000 through the issuance of up to 20,000,000 units (the "Units") in the capital of the Company at a price of $0.18 per Unit (the "Offering"). Gross...
Themefolio
Profiler
Peergroup
© Newsfile
29.03.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Announces New Online B2C Subscription Business
News Preview
Toronto, Ontario--(Newsfile Corp. - March 29, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce its new B2C online subscription-based business to be offered at www.insujet.com will be available to consumers in the coming weeks ahead.By utilizing fulfillment centers across Europe and Canada, we ensure...
Themefolio
Profiler
Peergroup
© Newsfile
27.03.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Reports Distribution Business Boasts Margins of 70%+
News Preview
Engages With Sol-MillenniumToronto, Ontario--(Newsfile Corp. - March 27, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to report that the Company's InsuJet™ needle-free injection device is actively sold in 11 countries through NuGen's distributor and wholesale network.InsuJet™ will soon be readily...
Themefolio
Profiler
Peergroup
© Newsfile
10.03.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Announces the Return of Veronique Laberge as Chief Financial Officer and Corporate Secretary
News Preview
Toronto, Ontario--(Newsfile Corp. - March 10, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce that the Board of Directors has re-appointed Ms. Veronique Laberge as Chief Financial Officer and Corporate Secretary of the Company. "I am excited to return into the CFO role at NuGen and work with the new...
Themefolio
Profiler
Peergroup
© Newsfile
03.03.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical's Needle-Free Injection Device, InsuJet(TM) Delivers Increased Efficacy of Insulin for Diabetic Patient Care
News Preview
Results Provide over 40% Faster Uptake of InsulinToronto, Ontario--(Newsfile Corp. - March 3, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") reports its needle-free injection device, InsuJet™ provides over 40% faster insulin uptake[1] and significantly faster onset of action in diabetic patients compared to needle...
Themefolio
Profiler
Peergroup
© Newsfile
28.02.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Announces the Appointment of Tony Di Benedetto as Executive Chairman and Director
News Preview
Toronto, Ontario--(Newsfile Corp. - February 28, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce that the Board of Directors has appointed Mr. Tony Di Benedetto as Executive Chairman and Director."I was approached by NuGen's new CEO, Richard Buzbuzian, who I had tremendous success with having built...
Themefolio
Profiler
Peergroup
© Newsfile
22.02.2023
ISIN: CA67054F1009

NuGen Medical Devices Inc.
NGMD

LISTED

TSX
NuGen Medical Devices Inc. Announces the Appointment of Richard Buzbuzian as President, CEO and Director
News Preview
Toronto, Ontario--(Newsfile Corp. - February 22, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company") is pleased to announce that the Board of Directors has appointed Richard Buzbuzian as President, CEO and Director."InsuJet™, our needle-free injection device has tremendous sales opportunity globally and is approved for sale in 42...
Themefolio
Profiler
Peergroup

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

© 2026 Select Sector SPDRs

* * *

More Sector related Investment Ideas
© 2026 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Saturday, 17.01.2026, Calendar Week 03, 17th day of the year, 348 days remaining until EoY.